DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Carbasalate calcium
Carbasalate calcium
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
Specifications of Approved Drug Compound Library
Aggressive Imaging in Young Children on Antithrombotic Therapy With
Statistical Analysis Plan – Part 1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Study Protocol
Pharmaceutical Appendix to the Tariff Schedule 2
EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Pharmaceutical Appendix to the Harmonized Tariff
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
(12) Patent Application Publication (10) Pub. No.: US 2010/0286160 A1 Gilbert Et Al
WO 2013/020527 Al 14 February 2013 (14.02.2013) P O P C T
Guideline Appendices PDF 664 KB
Inf Rmation for People Who Use Anticoagulants
Risk Factors for Venous Thromboembolism in Patients Treated for Differentiated Thyroid Carcinoma
Head Injury Partial Update
Method and Use for Increasing Efficacy of Anti-Adhesive Compositions in Controlling Inflammation and Pain
Top View
Inflammation/Immunology
PDF (Guidelines for ATC Classification and DDD Assignment)
Supplementary Appendix
Non-Steroidal Anti-Inflammatory Drugs for Acute Low Back Pain Van Der Gaag, Wendelien H; Roelofs, Pepijn Ddm; Enthoven, Wendy Tm; Van Tulder, Maurits W; Koes, Bart W
Substituted Piperazines As CB1 Antagonists
Project SCYLLA
Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
Marrakesh Agreement Establishing the World Trade Organization
Product List
Nsaids and Cardiovascular Drugs in Neurodegenerative and Cerebrovascular Diseases
Customs Tariff - Schedule
A Retrospective Analysis of Patients Treated for Superficial Vein Thrombosis
Pharmaceutical Compositions Comprising Prasugrel And
Pharmaabkommen A1 E
NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
Cyclooxygenase Selectivity of Nonsteroidal Anti-Inflammatory Drugs and Risk of Stroke
Low Dosage Carbasalate Calcium and Tinnitus
List of Texts Adopted at the November 2015 Session of the European Pharmacopoeia Commission
Download Product Insert (PDF)
BOC Sciences
CVMP Acetylsalicylic Acid & Salts Summary Report
Recommendations of the Dutch Harm-Wrestling Task Force
Harmonized Tariff Schedule of the United States (2006) (Rev
General Agreement on Tariffs Andtrade
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Acetylsalicylic Acid and Salts
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Pharmaceutical Appendix to the Tariff Schedule 2
Renaspirin Powder
Energies for Life Tél
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Summary of Product Characteristics 1. NAME of the MEDICINAL
(CD-P-PH/PHO) Report Classification/Justifica
FDA Briefing Document
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Review Search Strategy
3M Company's Comments July 19, 2019
Antithrombotic Treatment After Stroke Due to Intracerebral Haemorrhage
(12) Patent Application Publication (10) Pub. No.: US 2013/0095095 A1 Lines (43) Pub
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
CENTRAL Strategy
Product List 2020 BIOTECH and FERMENTATION PROSTAGLANDINS CORTICOSTEROIDS & HORMONES SYNTHESIS FRANCOPIA Product Name Business Unit Therapeutic Class ATC4 Page